Cara Historical Income Statement
| CARA Stock | USD 0.76 0.01 1.33% |
Historical analysis of Cara Therapeutic income statement accounts such as Interest Expense of 1 M, Selling General Administrative of 15.7 M or Other Operating Expenses of 79.1 M can show how well Cara Therapeutic performed in making a profits. Evaluating Cara Therapeutic income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cara Therapeutic's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Cara Therapeutic latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cara Therapeutic is a good buy for the upcoming year.
Cara |
About Cara Income Statement Analysis
Cara Therapeutic Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cara Therapeutic shareholders. The income statement also shows Cara investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Cara Therapeutic Income Statement Chart
Cara Therapeutic Income Statement is one of the three primary financial statements used for reporting Cara's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Cara Therapeutic revenue and expense. Cara Therapeutic Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Cara Therapeutic's Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 1 M, whereas Selling General Administrative is forecasted to decline to about 15.7 M. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Cara Therapeutic. It is also known as Cara Therapeutic overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Cara Therapeutic income statement and represents the costs associated with goods and services Cara Therapeutic provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Revenue
Total revenue comprises all receipts Cara Therapeutic generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most accounts from Cara Therapeutic's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cara Therapeutic current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cara Therapeutic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.At present, Cara Therapeutic's Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 1 M, whereas Selling General Administrative is forecasted to decline to about 15.7 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 112.1M | 122.1M | 136.0M | 77.9M | Cost Of Revenue | 1.6M | 7.3M | 6.4M | 6.1M |
Cara Therapeutic income statement Correlations
Click cells to compare fundamentals
Cara Therapeutic Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cara Therapeutic income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 370K | 198K | 209K | 248K | 259K | 498.1K | |
| Selling General Administrative | 17.7M | 21.7M | 29.4M | 30.3M | 27.6M | 15.7M | |
| Other Operating Expenses | 131.6M | 129.7M | 112.1M | 129.4M | 142.5M | 79.1M | |
| Operating Income | (111.7M) | 5.4M | (89.1M) | (87.5M) | (121.5M) | (115.4M) | |
| Ebit | (111.7M) | 5.4M | (89.1M) | (87.5M) | (121.5M) | (115.4M) | |
| Research Development | 113.8M | 107.9M | 82.7M | 91.9M | 108.4M | 62.2M | |
| Ebitda | (111.5M) | 5.6M | (88.8M) | (87.3M) | (121.2M) | (115.2M) | |
| Cost Of Revenue | 113.8M | 107.1M | 1.6M | 7.3M | 6.4M | 6.1M | |
| Total Operating Expenses | 131.6M | 129.7M | 112.1M | 122.1M | 136.0M | 77.9M | |
| Income Before Tax | (107.2M) | 7.7M | (88.4M) | (85.5M) | (118.5M) | (112.6M) | |
| Total Other Income Expense Net | 4.5M | 2.3M | 642K | 2.1M | 3.0M | 3.1M | |
| Net Income | (106.4M) | 8.4M | (88.2M) | (83.4M) | (118.5M) | (112.6M) | |
| Income Tax Expense | (816K) | (691K) | (248K) | (2.1M) | (1.9M) | (1.8M) | |
| Total Revenue | 19.9M | 135.1M | 23.0M | 41.9M | 21.0M | 25.2M | |
| Gross Profit | 19.9M | 28.0M | 23.0M | 34.6M | 14.5M | 14.2M | |
| Net Income From Continuing Ops | (106.4M) | 8.4M | (88.4M) | (85.5M) | (116.5M) | (110.7M) | |
| Net Income Applicable To Common Shares | (106.4M) | 8.4M | (88.4M) | (85.5M) | (76.9M) | (80.8M) | |
| Tax Provision | (204K) | (389K) | (816K) | (691K) | (255K) | 0.0 | |
| Non Operating Income Net Other | 4.5M | 2.3M | 642K | 2.1M | 2.4M | 2.0M | |
| Reconciled Depreciation | 370K | 198K | 209K | 248K | 238K | 229.3K |
Pair Trading with Cara Therapeutic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cara Therapeutic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cara Therapeutic will appreciate offsetting losses from the drop in the long position's value.Moving against Cara Stock
| 0.71 | PDEX | Pro Dex Earnings Call Today | PairCorr |
| 0.61 | MHUA | Meihua International | PairCorr |
| 0.49 | ZJYL | JIN MEDICAL INTERNATIONAL | PairCorr |
The ability to find closely correlated positions to Cara Therapeutic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cara Therapeutic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cara Therapeutic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cara Therapeutic to buy it.
The correlation of Cara Therapeutic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cara Therapeutic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cara Therapeutic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cara Therapeutic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cara Therapeutic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Cara Stock analysis
When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Cara Therapeutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.387 | Quarterly Revenue Growth (0.08) | Return On Assets (0.49) | Return On Equity (1.10) |
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.